USFDA concludes inspection at Lupin’s Goa facility

20 Sep 2021 Evaluate

The United States Food and Drug Administration (USFDA) has concluded an inspection at Lupin’s Goa facility in India. The inspection was carried out from September 6, 2021 to September 18, 2021 and closed with seven observations.

The company is confident of addressing the observations satisfactorily and is committed to be compliant with Good Manufacturing Practice standards across all its facilities.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×